These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17225303)

  • 1. Statin effective in preventing recurrent stroke.
    Duke Med Health News; 2006 Nov; 12(11):2. PubMed ID: 17225303
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a "best" statin drug?
    Johns Hopkins Med Lett Health After 50; 2004 Jan; 15(11):4-5. PubMed ID: 14983817
    [No Abstract]   [Full Text] [Related]  

  • 3. [Regarding LDL cholesterol: the lower, the better (interview by Dr. Dirk Einecke)].
    Nissen S
    MMW Fortschr Med; 2004 Mar; 146(13):65. PubMed ID: 15219143
    [No Abstract]   [Full Text] [Related]  

  • 4. [Following the ASCOT Study. A statin for every hypertensive patient?].
    MMW Fortschr Med; 2003 Apr; 145(16):8. PubMed ID: 14606391
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol: low is good. Lower is better. PROVE IT has doctors rethinking how to treat high cholesterol and what's a good target.
    Harv Heart Lett; 2004 May; 14(9):3. PubMed ID: 15153372
    [No Abstract]   [Full Text] [Related]  

  • 6. [After TIA and stroke: a statin for secondary prevention?].
    MMW Fortschr Med; 2006 Jun; 148(24):10. PubMed ID: 16850798
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins: not just for the young or the faint of heart.
    Coull BM; Johnston SC
    Neurology; 2009 Feb; 72(8):684-5. PubMed ID: 19237695
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lowering of cholesterol. What role is played by the choice of statins?].
    März W
    MMW Fortschr Med; 2004 Sep; 146(35-36):55. PubMed ID: 15540544
    [No Abstract]   [Full Text] [Related]  

  • 9. [High-dose statin in ischemic stroke reduces the risk of recurrent stroke].
    Crisby M; Olsson AG
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3541-3. PubMed ID: 19133582
    [No Abstract]   [Full Text] [Related]  

  • 10. [Coronary disease patient has already LDL of 100 mg/dl. Why lipid lowering is still worthwhile].
    MMW Fortschr Med; 2005 Mar; 147(12):4. PubMed ID: 15832778
    [No Abstract]   [Full Text] [Related]  

  • 11. [Considerable LDL lowering is advantageous].
    MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders].
    Z Kardiol; 1998 Apr; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894
    [No Abstract]   [Full Text] [Related]  

  • 13. [Decreasing blood lipids for prevention of coronary heart disease--discussion of the "permissive LDL level". Diagnostic imaging facilitates therapeutic decision].
    MMW Fortschr Med; 2001 Mar; 143(13):48-9. PubMed ID: 11332020
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural statins and stroke.
    Wierzbicki AS; Crook MA; Mikhailidis DP; Winder AF
    Circulation; 2000 Jan; 101(3):E45. PubMed ID: 10645940
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal of atherosclerosis with aggressive lipid lowering.
    Farmer JA
    Curr Atheroscler Rep; 2005 Mar; 7(2):86-7. PubMed ID: 15727721
    [No Abstract]   [Full Text] [Related]  

  • 16. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
    MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
    [No Abstract]   [Full Text] [Related]  

  • 17. [CARDS confirms usefulness of LDL lowering in type 2 diabetics].
    Bern VH
    Praxis (Bern 1994); 2004 Oct; 93(44):1 p following 1830. PubMed ID: 15559908
    [No Abstract]   [Full Text] [Related]  

  • 18. [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)].
    März W
    MMW Fortschr Med; 2004 Jul; 146(27-28):53. PubMed ID: 15526673
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study.
    Farsang C; Athyros V; Gaw A;
    Curr Med Res Opin; 2007 Aug; 23(8):1945-56. PubMed ID: 17626713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New LDL goals: even lower?
    Johns Hopkins Med Lett Health After 50; 2004 Jul; 17(5):1-2, 7. PubMed ID: 15233099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.